Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.
about
Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-AnalysisBaseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort study.Prognosis of CKD patients receiving outpatient nephrology care in Italy.The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease.Epidemiology of low-proteinuric chronic kidney disease in renal clinicsVascular disease, ESRD, and death: interpreting competing risk analyses.Epidemiology and Public Health Concerns of CKD in Older Adults.Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profilingCigarette smoking and chronic kidney diseases.Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease.The association of alcohol and smoking with CKD in a Japanese nationwide cross-sectional survey.Association of pre-operative estimated GFR on post-operative pulmonary complications in laparoscopic surgeries.Validation of chronic kidney disease risk categorization system in Chinese patients with kidney disease: A cohort study.Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).Plasma B-type natriuretic peptide level predicts kidney prognosis in patients with predialysis chronic kidney disease.Structural and Functional Changes in Human Kidneys with Healthy Aging.Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial.Prognosis of chronic kidney disease with normal-range proteinuria: The CKD-ROUTE study.Effects of nicorandil on the reduction of BNP levels in patients with chronic kidney disease.The 1-year decline in estimated glomerular filtration rate (eGFR) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same.Stopping renin-angiotensin system inhibitors in chronic kidney disease: predictors of responseAn association between serum γ-glutamyltransferase and proteinuria in drinkers and non-drinkers: a Japanese nationwide cross-sectional survey
P2860
Q26764823-E3E71773-8AB2-40E2-9A9C-18027C8D482FQ34831465-B3C9408F-FCD8-4274-AE6B-0E7F4B6A27B7Q35985791-1DE25696-C5BA-41B3-B5EF-7DD32CD9586FQ36259972-A167ED97-6FAE-424A-8940-CD2DDCD2EF80Q36284146-E10514B5-B615-4D53-AA33-10D8A0677ED9Q36294356-38675C3F-2390-468A-8BB7-0C85FFEA540AQ36410394-5C85B406-C8B7-4AFC-81F8-5722B5484724Q36910790-3EF74C8B-6D81-4939-9298-6DCE1524B1ACQ37967043-1E11517A-4F50-48B5-959C-55067D0456EFQ38018816-C54562A3-A7C4-4697-8022-E58509735306Q38919584-3655CBB0-1707-4C4A-A428-E1F9D5B1C55AQ40106923-1C19FFF4-C29A-4C01-95AA-6B5EB89FDAA7Q41702576-2B110DA5-5CA6-42B1-8922-79A83DD24C0AQ42272174-76A6276A-165D-4811-A696-DB53B3B67EAFQ43662566-B5A25B48-C310-4F2B-8217-21EEEB50F8A5Q43667043-411BDC4A-6903-4094-9CD5-E64F3387DEA0Q47735571-40986C68-334E-4AEE-8B23-08D75103666FQ48226261-8C35E991-60C2-4A89-BCFF-0906A75D0213Q48939498-06D9413B-D51B-40DE-BEA5-CF94FFC6FDF1Q51161758-5D68E949-AE1D-413A-8F65-ECD7C5110A3EQ57214519-D75840AD-5FCE-4411-90B2-C9C4535D37E6Q58362705-76D95861-8A2A-4779-B4F2-FE39EEEFA652
P2860
Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Impact of age and overt protei ...... disease in a referred cohort.
@ast
Impact of age and overt protei ...... disease in a referred cohort.
@en
Impact of age and overt protei ...... disease in a referred cohort.
@nl
type
label
Impact of age and overt protei ...... disease in a referred cohort.
@ast
Impact of age and overt protei ...... disease in a referred cohort.
@en
Impact of age and overt protei ...... disease in a referred cohort.
@nl
prefLabel
Impact of age and overt protei ...... disease in a referred cohort.
@ast
Impact of age and overt protei ...... disease in a referred cohort.
@en
Impact of age and overt protei ...... disease in a referred cohort.
@nl
P2093
P2860
P356
P1476
Impact of age and overt protei ...... disease in a referred cohort.
@en
P2093
Harumi Kitamura
Keiko Yasuda
Koichi Sasaki
Ryohei Yamamoto
Terumasa Hayashi
Tomonori Kimura
Yasuyuki Nagasawa
Yoshitaka Isaka
Yoshitsugu Obi
P2860
P304
P356
10.2215/CJN.08061109
P577
2010-06-17T00:00:00Z